HB 1772 (2026)
Allow NH to participate in ibogaine clinical trials
This bill is still active.
Last updated 2026-01-31 4:33 am
Summary:
Allows New Hampshire to participate in a multistate consortium to conduct clinical trials using ibogaine as an investigational new drug for the treatment of substance use disorder and other conditions.
Status:
The data you see here is pulled daily from official government databases. The bill summary is created by Citizens Count staff. Learn more about our methodology for summarizing and updating bills. Visit the official New Hampshire government website for a deep-dive on this bill.
Browse related articles and bills:
